Archive · 24 Jul 2025
India-UK Trade Pact Aims to Boost Pharma, MedTech Exports
India and the UK have made a deal to help Indian companies sell medicines and medical devices in the UK.
This deal should make it easier and faster for Indian companies to get their products approved.
It might also lower the prices of medicines in the UK.
The goal is to boost exports and investment, helping both countries.
Medical device companies are hoping for easier approval processes too.
The deal includes a zero-tariff regime on many products.
Both countries are looking forward to the benefits of this agreement.
India's pharma and MedTech sectors anticipate faster approvals and reduced regulatory hurdles in the UK.
The UK's free trade agreement (FTA) with India aims to enhance procedural flexibility for Indian pharma companies.
The agreement is expected to reduce product registration timelines, potentially to under a year.
Indian pharma exports to the UK totaled $914 million in FY24, with medical devices worth Rs 1015 crore.
The FTA could enhance competitiveness and drive foreign direct investment in both sectors.
- Who
- Indian pharma and MedTech companies.
- What
- Trade agreement between India and the UK to ease regulatory processes for pharmaceutical and medical device exports.
- When
- FY24 (for export data)
- Where
- UK
- Why
- To enhance competitiveness, streamline approvals, and boost trade between India and the UK.
MedTech Concerns
Pharma Perspectives
Regulatory Hurdles
MedTech Concerns
Focus on regulatory approval costs and timelines.
Pharma Perspectives
Focus on tariff restrictions.
Rules of Origin
MedTech Concerns
Need for monitoring 'Rules of Origin' to prevent misuse of the FTA.
Pharma Perspectives
N/A
- Pharma Exports to UK (FY24)
- $914 million
- Medical Device Exports to UK (2024)
- Rs 1015 crore
- Medical Device Imports from UK (2024)
- Rs 2,295 crore
- Anticipated Product Registration Timeline Reduction
- Less than a year
- Aim of FTA
- Strengthen supply chains, enhance access to affordable medicines, and drive foreign direct investment